Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Aino Health AB (publ) (AINO.ST)
Stockholm, SE
Aino Health AB (publ), a Swedish company based in Stockholm, specializes in delivering comprehensive corporate health management solutions to both private and public organizations throughout Finland. Their flagship offering is HealthManager, a Software-as-a-Service (SaaS) platform equipped with tools for health surveys, analytical insights, exposure checks, and compliance with security and GDPR regulations, along with an integrated e-learning module. Beyond the software, Aino Health provides a range of additional services, including telemedicine, professional support (such as analytics, management/employee guidance, and well-being programs), and onboarding assistance covering project management, implementation, and training. The company also extends its services to a diverse network of partners, including occupational health providers, insurance companies, IT firms, HR/payroll service centers, and various healthcare practitioners.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +23.33% | +19.35% | +3.50% | -8.07% | -12.94% | -22.51% | -5.13% | -70.94% | -84.70% | -98.77% | -98.77% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Healthcare Information Services: +14.2%+9.1% Q1'26: -25.0% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%+56.7% ★ Q1'26: -300.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-7.6% Q1'26: -19.2% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-20.1% Q1'26: -36.5% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%— Q1'26: +175.5% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+42.6% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-3.58× Q1'26: -1.51× (vs Q1'25)
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
|---|---|---|---|---|---|---|---|
| Revenue |
19.25M
est: 18.00M (+7.0%)
|
20.75M
est: 21.72M (-4.4%)
|
25.87M
est: 27.23M (-5.0%)
|
24.92M
est: 25.20M (-1.1%)
|
23.04M
est: 32.60M (-29.3%)
|
19.91M
est: 80.10M (-75.1%)
|
23.92M
est: 136.10M (-82.4%)
|
| EBITDA |
-28.95M
est: -7.61M (-280.5%)
|
-18.75M
est: -9.18M (-104.2%)
|
-12.87M
est: -11.51M (-11.8%)
|
-9.95M
est: -10.65M (+6.6%)
|
-12.09M
est: -13.78M (+12.3%)
|
-12.26M
est: -33.86M (+63.8%)
|
-7.53M
est: -57.53M (+86.9%)
|
| EBIT |
-31.62M
est: -9.27M (-241.0%)
|
-20.64M
est: -11.19M (-84.5%)
|
-14.91M
est: -14.03M (-6.3%)
|
-11.87M
est: -12.98M (+8.6%)
|
-13.92M
est: -16.80M (+17.1%)
|
-14.17M
est: -41.27M (+65.7%)
|
-9.57M
est: -70.12M (+86.4%)
|
| Net Income |
-31.79M
est: -349.61M (+90.9%)
|
-22.01M
est: -122.01M (+82.0%)
|
-15.28M
est: -45.76M (+66.6%)
|
-13.17M
est: -45.13M (+70.8%)
|
-15.22M
est: -16.72M (+8.9%)
|
-14.96M
est: 53.49M (-128.0%)
|
-10.66M
est: 180.52M (-105.9%)
|
| SGA |
15.05M
est: 7.96M (+89.0%)
|
14.09M
est: 9.61M (+46.6%)
|
12.90M
est: 12.05M (+7.1%)
|
10.42M
est: 11.15M (-6.5%)
|
13.08M
est: 14.42M (-9.3%)
|
10.89M
est: 35.43M (-69.3%)
|
5.92M
est: 60.20M (-90.2%)
|
| EPS |
-4.46
est: -2.44 (-83.0%)
|
-1.04
est: -0.85 (-22.3%)
|
-0.73
est: -0.32 (-128.8%)
|
-0.60
est: -0.31 (-90.7%)
|
-0.54
est: -0.12 (-363.3%)
|
-0.33
est: 0.37 (-188.5%)
|
-0.13
est: 1.26 (-110.3%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jyrki Eklund | Chief Executive Officer, President, MD, Acting Director of Aino Health Sweden & Germany and Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AINO.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
